UPDATES: NCCN Guidelines® and NCCN Guidelines for Patients®
NCCN Flash Update sent July 23, 2013
Because of anticipated significant overlap between the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Cervical Cancer Screening and other current guidelines, the NCCN Guidelines® for Cervical Cancer Screening are being replaced with endorsements of the following newly updated guidelines:
- For the prevention and early detection of cervical cancer, the American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol 2012;137:516-542. Available at: http://ajcp.ascpjournals.org/content/137/4/516.long
- For the management of abnormal cervical screening tests and cancer precursors, the 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis 2013;17(5 Suppl 1):S1-S27. Available at: http://www.asccp.org/
NCCN has published updates to the NCCN Guidelines for Patients®: Prostate Cancer. The NCCN Guidelines for Patients®: Prostate Cancer is available as Version 1.2013 on NCCN.com and NCCN.org.
For the complete updated versions of the NCCN Guidelines®, the NCCN Drugs & Biologics Compendium (NCCN Compendium®), and the NCCN Chemotherapy Order Templates (NCCN Templates®), please visit NCCN.org.
To access the NCCN Biomarkers Compendium™, please visit NCCN.org/biomarkers.
To view the NCCN Guidelines for Patients®, please visit NCCN.com.
Free NCCN Guidelines mobile apps for iPad and Android are now available! Visit NCCN.org/apps